may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..
"we can only imagine the terror that she experienced on her own, dying on the floor in pain..